Journal of Oncology Pharmacy Practice,
Journal Year:
2023,
Volume and Issue:
30(8), P. 1302 - 1306
Published: Oct. 17, 2023
Introduction
Patients
diagnosed
with
cancer
are
at
an
increased
risk
of
infection.
Vaccines
remain
one
the
most
critical
public
health
strategies
in
limiting
infectious
diseases,
a
heightened
importance
patients.
Data
across
general
US
population
indicates
that
vaccine
adherence
rates
suboptimal
all
adult
schedules.
This
study
aims
to
define
within
oncology
population.
Methods
retrospective
cohort
includes
patients
new
diagnosis.
Vaccine
administrations
for
COVID-19
(SARS-CoV-2),
influenza,
pneumococcal,
tetanus/diphtheria/pertussis
(TDaP),
herpes
zoster
(RZV),
human
papillomavirus
(HPV),
and
hepatitis
B
(hepB)
were
assessed.
The
primary
outcome
was
complete
adherence.
Results
Two
hundred
eighty-three
included.
median
age
diagnosis
63
years
old,
subjects
females
(60%).
two
common
malignancies
gastrointestinal
breast
26.5%
15.2%,
respectively.
Suboptimal
observed
entire
Complete
only
1.4%
specific
as
follows,
SARS-CoV-2:
38.9%;
influenza:
11.4%;
pneumococcal:
12.7%;
TDaP:
13.1%;
RZV:
3.5%;
HPV:
0%;
hepB:
34%.
Among
schedules
assessed,
SARS-CoV-2
vaccination
highest
38.9%
being
fully
adherent
73%
receiving
least
dose.
Conclusion
Lower
compared
currently
published
rates.
Providers
pharmacists
can
play
role
assessing
counseling
on
before
chemotherapy
is
initiated
after
remission
obtained.
ABSTRACT
The
COVID‐19
vaccine
is
indicated
for
children
with
acute
lymphoblastic
leukemia
(ALL),
yet
patients
and
caregivers
may
have
unique
questions
concerns
about
vaccination.
We
surveyed
ALL
or
their
(
N
=
44)
to
understand
factors
contributing
the
decision
vaccinate
identify
cues
vaccination
tailored
this
population.
For
of
unvaccinated
patients,
lack
knowledge
safety
efficacy
were
most
reported
barriers
A
recommendation
from
a
hematologist/oncologist
data
in
cited
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 3, 2024
Abstract
Background
Concerns
about
side
effects
and
treatment
interactions
delays
may
contribute
to
COVID-19
vaccine
hesitancy
amongst
cancer
patients.
In
the
large
prospective
SerOzNET
study
of
response
in
children
adults
with
cancer,
beliefs,
physician-
participant-reported
adverse
events
(AE),
interruptions
quality
life
(QoL)
were
studied.
Methods
The
Australian
experience
gave
a
unique
opportunity
vaccination
an
infection-
vaccine-naïve
population.
Patients
current
or
recent
solid
hematological
malignancy,
aged
five
over,
had
serial
assessments
prior
following
multiple
SARS-CoV-2
vaccinations.
Electronic
surveys
administered
at
baseline
after
first,
second
third
doses
collect
beliefs
(Oxford
Confidence
Complacency
Scale),
patient-reported
toxicity
QoL
(QLQC30
PedsQL).
Detailed
data
collected
clinic
visits
from
medical
records.
Results
A
total
1385
(93%
BNT162b2),
least
1
dose
received
by
499
patients,
whom
only
seven
known
infection.
Vaccine
related
generally
positive.
There
no
vaccine-related
therapy.
AE
occurred
95%
recipients,
highest
ranked
severity
being
mild
36%
moderate,
severe
serious
31%,
19%
6%
respectively.
showed
significant
deterioration
post-vaccination.
Conclusion
This
robust
dataset
provides
evidence
regarding
safety
tolerance
cancer.
families
can
be
reassured
that
rates
AEs
are
comparable
general
population
do
not
impact
delivery
therapy
QoL.
Palliative & Supportive Care,
Journal Year:
2023,
Volume and Issue:
22(2), P. 289 - 295
Published: Aug. 1, 2023
Abstract
Background
Vaccine
hesitancy
has
become
prevalent
in
society.
Vulnerable
populations,
such
as
those
with
cancer,
are
susceptible
to
increased
morbidity
and
mortality
from
diseases
that
may
have
been
prevented
through
vaccination.
Objectives
Our
objective
was
determine
patient
perception
of
vaccine
efficacy
safety
sources
information
influence
decisions.
Methods
This
study
a
prospective
cross-sectional
survey
trial
conducted
March
10,
2022,
November
1,
at
Supportive
Care
Clinic.
Patients
completed
the
research
assistant
or
link.
defined
response
2
more
on
Parent
Attitudes
About
Childhood
Vaccines
(PACV-4).
Perception
along
importance
were
determined
by
questionnaire.
Results
Of
72
patients
who
PACV-4,
30
considered
vaccine-hesitant
(42%).
alone
(35),
23
(66%)
vaccine-hesitant;
help
coordinator
(37),
7
(19%)
vaccine-hesitant.
The
most
important
source
for
decision-making
their
doctor
(82%,
95%
CI
73–89),
followed
family
(42%,
32–52),
news/media
(31%,
22–41),
social
media
(9%,
4–16).
Clinical
demographic
factors
including
age,
gender,
race/ethnicity,
education
level,
location
residence
not
associated
hesitancy.
Significance
results
is
present
among
advanced
cancer.
high
value
given
doctor’s
recommendation
suggests
universal
precautions
regarding
be
an
effective
intervention.
Current Medical Research and Opinion,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 9
Published: Dec. 24, 2024
Objective
The
recent
outbreak
of
monkeypox
(mpox)
poses
significant
public
health
challenges,
particularly
for
immunocompromised
populations
such
as
patients
with
cancer.
However,
misinformation
a
challenge
during
new
outbreaks
chronic
diseases,
observed
the
COVID-19
pandemic.
Therefore,
we
aimed
to
assess
perspectives
and
knowledge
cancer
on
mpox
their
willingness
receive
vaccination.
JCR Journal of Clinical Rheumatology,
Journal Year:
2023,
Volume and Issue:
30(1), P. e1 - e8
Published: Nov. 9, 2023
The
aim
of
this
study
was
to
measure
COVID-19
vaccine
hesitancy
among
rheumatology
outpatients
from
an
early
"hotspot"
during
the
initial
period
availability.In
March
2021,
a
Web-based
survey
sent
7505
adults
seen
at
Rheumatology
Division
in
New
York
City.
We
evaluated
characteristics
associated
with
3
categories
vaccination
status:
declined,
undecided,
and
willing/already
received.
used
multinomial
logistic
regression
models
calculate
relative
risk
ratios
assessing
predictors
status.Among
2384
(32%)
respondents
(80%
female,
87%
White,
59%
systemic
rheumatic
disease),
2240
(94.0%)
were
received
vaccination,
88
(3.7%)
56
(2.3%)
declined.
Compared
those
vaccinated,
declining
or
undecided
younger,
more
likely
identified
as
Black
Hispanic/Latinx,
had
lower
household
income
educational
attainment.
Immunosuppressive
medication
use
did
not
differ
groups.
After
multivariable
adjustment,
every
1-year
increase
age
0.96
being
versus
vaccinated.
Respondents
identifying
White
higher
ratio
(4.29
[95%
confidence
interval,
1.96-9.36]),
Hispanic/Latinx
non-Hispanic/non-Latinx
(2.81
1.29-6.09]).
Those
least
believe
general
importance
safety
efficacy
vaccine.Among
patients
City
without
disease,
uptake
high
after
its
availability.
Sociodemographic
but
medication-related
factors
hesitancy;
these
findings
can
inform
future
programs.
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: Nov. 28, 2023
Introduction
Vaccines
stand
amongst
the
most
effective
medical
interventions
for
management
of
infectious
diseases,
and
are
pivotal
tools
public
health.
The
acceptance
vaccines
is
heavily
influenced
by
perceptions
efficacy,
safety
other
modifiable
factors.
Purpose
This
cross-sectional
study
sought
to
identify
examine
factors
that
can
help
address
COVID-19
vaccine
hesitancy
among
cancer
patients.
Methods
was
conducted
between
February
April
2021
using
an
online
survey
questionnaire
comprising
four
domains.
administered
patients
in
Jordan.
Results
Among
1,029
who
completed
(response
rate=
73%),
58%
(n=597)
expressed
willingness
(intent)
take
vaccine.
Notably,
72.5%
(n=433)
those
intending
were
currently
undergoing
treatment.
Knowledge
awareness
played
a
significant
role,
with
54.3%
considering
them
essential
acceptance.
Fear
infection
significantly
(p<0.001),
66.8%
expressing
concern
about
potential
infections.
Peer
encouragement
also
crucial
factor,
as
82.4%
regarded
it
important
driver
influencing
(p<0.001).
Conclusion
encouragement,
awareness,
fear
emerged
primary
associated
greater
active
malignancies.
Study
results
suggest
providing
personalized
tailored
information
vaccinations,
focusing
on
interactions
its
treatment,
potentially
excellent
strategies
improving
Acta Haematologica,
Journal Year:
2024,
Volume and Issue:
147(5), P. 543 - 554
Published: Feb. 16, 2024
Introduction:
Despite
people
with
haematological
malignancies
being
particularly
vulnerable
to
severe
COVID-19
infection
and
complications,
vaccine
hesitancy
may
be
a
barrier
optimal
vaccination.
This
study
explored
attitudes
towards
vaccination
in
malignancies.
Methods:
People
at
nine
Australian
health
services
were
surveyed
between
June
October
2021.
Sociodemographic
clinical
characteristics
collected.
Attitudes
using
the
Oxford
Vaccine
Hesitancy
Scale,
Confidence
Complacency
Disease
Influenced
Acceptance
Scale-Six.
Open-ended
comments
qualitatively
analysed.
Results:
A
total
of
869
(mean
age
64.2
years,
43.6%
female)
participated.
Most
participants
(85.3%)
reported
that
they
had
received
least
one
dose.
Participants
who
younger,
spoke
English
as
non-dominant
language,
shorter
time
since
diagnosis
less
likely
vaccinated.
Those
female
or
their
language
greater
side-effect
concerns.
Younger
concerns
about
impacting
treatment.
Conclusion:
high
uptake;
however,
targeted
education
for
specific
participant
groups
address
concerns,
given
need
boosters.
